IFNG and neoplasm: In this setting, we suspect that IFNγ produced by CAR-T and endogenous immune cells acts as a double-edged sword in that it induces expression of Qa-1b (and potentially other inhibitory proteins) on tumor cells but also helps recruit and activate endogenous immunity that can both aid and abet CAR-T therapy.